Loading...
Market
Which pharmaceutical company will be most affected by the Inflation Reduction Act by the end of 2024?
2
Resolution / Starting Odds
Pfizer • 25%
Johnson & Johnson • 25%
Merck & Co. • 25%
Other • 25%
Financial reports and stock performance analysis
Story
Biden Administration Caps Prescription Drug Costs Under Inflation Reduction Act, Benefiting 3.3 Million Wisconsinites
Jul 25, 2024, 12:09 AM
President Joe Biden announced that his administration has successfully taken on big pharmaceutical companies, resulting in significant reductions in prescription drug costs for seniors. This achievement is part of the broader Inflation Reduction Act, which aims to cap prescription drug costs for millions of American families, including 3.3 million residents of Wisconsin. Biden emphasized his commitment to continue fighting to lower drug costs for all Americans, not just seniors. The announcement comes after a debate gaffe where Biden mistakenly said, 'We finally beat Medicare,' leading to questions about his campaign.
View original story
Similar markets
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Significantly lower • 25%
Moderately lower • 25%
No change • 25%
Higher • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
CVS • 25%
UNH • 25%
CI • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Yes • 50%
No • 50%
Significant cost reduction • 25%
Moderate cost reduction • 25%
Minimal cost reduction • 25%
No cost reduction • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Capping insulin costs • 25%
Capping prescription drug costs • 25%
Lowering overall healthcare costs • 25%
Free tax filing on IRS website • 25%